Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1).

Lennox BR, Tomei G, Vincent SA, Yeeles K, Pollard R, Palmer-Cooper E, Jones P, Zandi MS, Coles A.

J Neurol Neurosurg Psychiatry. 2018 Jun 11. pii: jnnp-2018-318124. doi: 10.1136/jnnp-2018-318124. [Epub ahead of print] No abstract available.

PMID:
29891740
2.

Can prebiotics assist in the management of cognition and weight gain in schizophrenia?

Kao AC, Burnet PWJ, Lennox BR.

Psychoneuroendocrinology. 2018 May 19;95:179-185. doi: 10.1016/j.psyneuen.2018.05.027. [Epub ahead of print]

PMID:
29883788
3.

Neuroimmunology 2017: making progress over 20 years.

Al-Diwani AA, Lennox BR.

Lancet Psychiatry. 2018 Jan;5(1):9-10. doi: 10.1016/S2215-0366(17)30482-0. No abstract available.

PMID:
29277216
4.

Adolescent Major Depressive Disorder: Neuroimaging Evidence of Sex Difference during an Affective Go/No-Go Task.

Chuang JY, Hagan CC, Murray GK, Graham JME, Ooi C, Tait R, Holt RJ, Elliott R, van Nieuwenhuizen AO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer IM, Suckling J.

Front Psychiatry. 2017 Jul 11;8:119. doi: 10.3389/fpsyt.2017.00119. eCollection 2017.

5.

Psychosis: an autoimmune disease?

Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR.

Immunology. 2017 Nov;152(3):388-401. doi: 10.1111/imm.12795. Epub 2017 Aug 3. Review.

PMID:
28704576
6.

Using Directed Acyclic Graphs in Epidemiological Research in Psychosis: An Analysis of the Role of Bullying in Psychosis.

Moffa G, Catone G, Kuipers J, Kuipers E, Freeman D, Marwaha S, Lennox BR, Broome MR, Bebbington P.

Schizophr Bull. 2017 Oct 21;43(6):1273-1279. doi: 10.1093/schbul/sbx013.

7.

NMDAR antibodies in first episode psychosis: conclusions too inflammatory given results? - Authors' reply.

Lee MM, Oke J, Palmer-Cooper EC, Lennox BR.

Lancet Psychiatry. 2017 May;4(5):356-357. doi: 10.1016/S2215-0366(17)30139-6. No abstract available.

PMID:
28456292
8.

Serum neuronal cell-surface antibodies in first-episode psychosis-Authors' reply.

Lennox BR, Pollak T, Palmer-Cooper EC, Scoriels L, Harrison PJ, Jones PB, Lang B, Crowley H, Marks J, Vincent A.

Lancet Psychiatry. 2017 Mar;4(3):187-188. doi: 10.1016/S2215-0366(17)30053-6. No abstract available.

PMID:
28236947
9.

Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Al-Diwani A, Pollak TA, Langford AE, Lennox BR.

Front Psychiatry. 2017 Feb 6;8:13. doi: 10.3389/fpsyt.2017.00013. eCollection 2017.

10.

When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain.

Arango C, Bernardo M, Bonet P, Cabrera A, Crespo-Facorro B, Cuesta MJ, González N, Parrabera S, Sanjuan J, Serrano A, Vieta E, Lennox BR, Melau M.

Rev Psiquiatr Salud Ment. 2017 Apr - Jun;10(2):78-86. doi: 10.1016/j.rpsm.2017.01.001. Epub 2017 Feb 8. English, Spanish.

11.

Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study.

Lennox BR, Palmer-Cooper EC, Pollak T, Hainsworth J, Marks J, Jacobson L, Lang B, Fox H, Ferry B, Scoriels L, Crowley H, Jones PB, Harrison PJ, Vincent A; PPiP study team.

Lancet Psychiatry. 2017 Jan;4(1):42-48. doi: 10.1016/S2215-0366(16)30375-3. Epub 2016 Dec 8.

12.

Economic impact of early intervention in psychosis services: results from a longitudinal retrospective controlled study in England.

Tsiachristas A, Thomas T, Leal J, Lennox BR.

BMJ Open. 2016 Oct 20;6(10):e012611. doi: 10.1136/bmjopen-2016-012611.

13.

Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.

Prüss H, Lennox BR.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1242-1247. doi: 10.1136/jnnp-2015-313000. Epub 2016 Jul 19. Review.

PMID:
27435086
14.

Functional MRI of emotional memory in adolescent depression.

Holt RJ, Graham JM, Whitaker KJ, Hagan CC, Ooi C, Wilkinson PO, van Nieuwenhuizen AO, Lennox BR, Sahakian BJ, Goodyer IM, Bullmore ET, Suckling J.

Dev Cogn Neurosci. 2016 Jun;19:31-41. doi: 10.1016/j.dcn.2015.12.013. Epub 2015 Dec 31.

15.

The Importance of Keeping in Mind the Diagnosis of N-Methyl-D-Aspartate Receptor Encephalitis.

Zandi MS, Lennox BR, Vincent A.

Biol Psychiatry. 2016 Aug 15;80(4):e15. doi: 10.1016/j.biopsych.2015.08.038. Epub 2015 Nov 14. No abstract available.

PMID:
26742924
16.

Aberrant brain responses to emotionally valent words is normalised after cognitive behavioural therapy in female depressed adolescents.

Chuang JY, J Whitaker K, Murray GK, Elliott R, Hagan CC, Graham JM, Ooi C, Tait R, Holt RJ, van Nieuwenhuizen AO, Reynolds S, Wilkinson PO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer I, Suckling J.

J Affect Disord. 2016 Jan 1;189:54-61. doi: 10.1016/j.jad.2015.09.008. Epub 2015 Sep 11.

17.

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.

Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB.

Lancet Psychiatry. 2015 Mar;2(3):258-270. doi: 10.1016/S2215-0366(14)00122-9. Epub 2015 Feb 25. Review.

18.

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.

Scoriels L, Salek RM, Goodby E, Grainger D, Dean AM, West JA, Griffin JL, Suckling J, Nathan PJ, Lennox BR, Murray GK, Bullmore ET, Jones PB.

Transl Psychiatry. 2015 Mar 31;5:e540. doi: 10.1038/tp.2015.26.

19.

Adolescents with current major depressive disorder show dissimilar patterns of age-related differences in ACC and thalamus.

Hagan CC, Graham JM, Tait R, Widmer B, van Nieuwenhuizen AO, Ooi C, Whitaker KJ, Simas T, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer IM, Suckling J.

Neuroimage Clin. 2015 Jan 7;7:391-9. doi: 10.1016/j.nicl.2014.12.019. eCollection 2015.

20.

Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series.

Zandi MS, Deakin JB, Morris K, Buckley C, Jacobson L, Scoriels L, Cox AL, Coles AJ, Jones PB, Vincent A, Lennox BR.

Schizophr Res. 2014 Dec;160(1-3):193-5. doi: 10.1016/j.schres.2014.11.001. Epub 2014 Nov 15. No abstract available.

PMID:
25468187
21.

Magnetic resonance imaging of a randomized controlled trial investigating predictors of recovery following psychological treatment in adolescents with moderate to severe unipolar depression: study protocol for Magnetic Resonance-Improving Mood with Psychoanalytic and Cognitive Therapies (MR-IMPACT).

Hagan CC, Graham JM, Widmer B, Holt RJ, Ooi C, van Nieuwenhuizen AO, Fonagy P, Reynolds S, Target M, Kelvin R, Wilkinson PO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer I, Suckling J.

BMC Psychiatry. 2013 Oct 5;13:247. doi: 10.1186/1471-244X-13-247.

22.

Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis.

Fornito A, Harrison BJ, Goodby E, Dean A, Ooi C, Nathan PJ, Lennox BR, Jones PB, Suckling J, Bullmore ET.

JAMA Psychiatry. 2013 Nov;70(11):1143-51. doi: 10.1001/jamapsychiatry.2013.1976.

PMID:
24005188
23.

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.

Deakin J, Lennox BR, Zandi MS.

Biol Psychiatry. 2014 Feb 15;75(4):284-91. doi: 10.1016/j.biopsych.2013.07.018. Epub 2013 Aug 26. Review.

PMID:
23988024
24.

Young people's views of UK mental health services.

Plaistow J, Masson K, Koch D, Wilson J, Stark RM, Jones PB, Lennox BR.

Early Interv Psychiatry. 2014 Feb;8(1):12-23. doi: 10.1111/eip.12060. Epub 2013 Jun 17. Review.

PMID:
23773401
25.

Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systems.

Dean AM, Goodby E, Ooi C, Nathan PJ, Lennox BR, Scoriels L, Shabbir S, Suckling J, Jones PB, Bullmore ET, Barnes A.

Psychol Med. 2013 Mar;43(3):591-602. doi: 10.1017/S0033291712001341. Epub 2012 Jun 18.

PMID:
22703698
26.

Antibody-mediated encephalitis and psychosis.

Pollak TA, Lennox BR, Vincent A, Nicholson TR.

Br J Psychiatry. 2012 Apr;200(4):344; author reply 344-5. doi: 10.1192/bjp.200.4.344. No abstract available.

PMID:
22474234
27.

Antibody-mediated encephalitis: a treatable cause of schizophrenia.

Lennox BR, Coles AJ, Vincent A.

Br J Psychiatry. 2012 Feb;200(2):92-4. doi: 10.1192/bjp.bp.111.095042.

PMID:
22297586
28.

Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study.

Nicholson TR, Ferdinando S, Krishnaiah RB, Anhoury S, Lennox BR, Mataix-Cols D, Cleare A, Veale DM, Drummond LM, Fineberg NA, Church AJ, Giovannoni G, Heyman I.

Br J Psychiatry. 2012 May;200(5):381-6. doi: 10.1192/bjp.bp.111.092007. Epub 2012 Jan 26.

PMID:
22282431
29.

A quantitative meta-analysis of fMRI studies in bipolar disorder.

Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET.

Bipolar Disord. 2011 Feb;13(1):1-15. doi: 10.1111/j.1399-5618.2011.00893.x. Review.

PMID:
21320248
30.

Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.

Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, Jones PB.

Psychol Med. 2011 May;41(5):949-58. doi: 10.1017/S0033291710002461. Epub 2010 Dec 23.

31.

Effects of modafinil on emotional processing in first episode psychosis.

Scoriels L, Barnett JH, Murray GK, Cherukuru S, Fielding M, Cheng F, Lennox BR, Sahakian BJ, Jones PB.

Biol Psychiatry. 2011 Mar 1;69(5):457-64. doi: 10.1016/j.biopsych.2010.09.043. Epub 2010 Dec 15.

PMID:
21109234
32.

Disease-relevant autoantibodies in first episode schizophrenia.

Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P, Coles AJ, Vincent A, Lennox BR.

J Neurol. 2011 Apr;258(4):686-8. doi: 10.1007/s00415-010-5788-9. Epub 2010 Oct 26. No abstract available.

33.

A longitudinal fMRI study of the manic and euthymic states of bipolar disorder.

Chen CH, Suckling J, Ooi C, Jacob R, Lupson V, Bullmore ET, Lennox BR.

Bipolar Disord. 2010 May;12(3):344-7. doi: 10.1111/j.1399-5618.2010.00801.x. No abstract available.

PMID:
20565443
34.

The clinical experience and potential of brain imaging in patients with mental illness.

Lennox BR.

Front Hum Neurosci. 2009 Dec 23;3:46. doi: 10.3389/neuro.09.046.2009. eCollection 2009. No abstract available.

35.

Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania.

Lennox BR, Jacob R, Calder AJ, Lupson V, Bullmore ET.

Psychol Med. 2004 Jul;34(5):795-802.

PMID:
15500300
36.

Mind and movement: the neuropsychiatry of movement disorders.

Lennox BR, Lennox GG.

J Neurol Neurosurg Psychiatry. 2002 Mar;72 Suppl 1:I28-I31. No abstract available.

37.

The functional anatomy of auditory hallucinations in schizophrenia.

Lennox BR, Park SB, Medley I, Morris PG, Jones PB.

Psychiatry Res. 2000 Nov 20;100(1):13-20.

PMID:
11090721
38.

Spatial and temporal mapping of neural activity associated with auditory hallucinations.

Lennox BR, Park SB, Jones PB, Morris PG.

Lancet. 1999 Feb 20;353(9153):644. No abstract available. Erratum in: Lancet 1999 Aug 7;354(9177):518. Park G [corrected to Park SB].

PMID:
10030336

Supplemental Content

Loading ...
Support Center